Neuroprotective therapies for multiple sclerosis and other demyelinating diseases
Crossref DOI link: https://doi.org/10.1186/s40893-016-0004-0
Published Online: 2016-04-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Villoslada, Pablo
Funding for this research was provided by:
Instituto de Salud Carlos III (ES) (PI12/01823)